These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 16273062)

  • 1. The patentability of medicinal inventions related to personalized medicine in Japan.
    Shimbo I; Cobden A; Sumikura K
    Nat Biotechnol; 2005 Nov; 23(11):1367-9. PubMed ID: 16273062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intellectual property protection for plant-related inventions in Europe.
    Fleck B; Baldock C
    Nat Rev Genet; 2003 Oct; 4(10):834-8. PubMed ID: 14526379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patentability of biotechnological inventions in countries of the Pacific Rim.
    Cox GB; Wong SS; Waters S; Santer VB
    Australas Biotechnol; 1994; 4(5):274-7. PubMed ID: 7765672
    [No Abstract]   [Full Text] [Related]  

  • 4. Patentability and perspectives of biotechnology large-scale applications.
    Dompé S
    Forum (Genova); 1999; 9(3 Suppl 3):113-7. PubMed ID: 10607856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enforcing pharmaceutical and biotech patent rights in China.
    Zhang YP; Deng MM
    Nat Biotechnol; 2008 Nov; 26(11):1235-40. PubMed ID: 18997760
    [No Abstract]   [Full Text] [Related]  

  • 6. Intellectual property rights in agriculture in the light of the debate on biotechnology: historical evolution and current situation.
    Gimelli F
    Ital J Biochem; 2000; 49(3-4):41-51. PubMed ID: 11508056
    [No Abstract]   [Full Text] [Related]  

  • 7. Patentability of synthetic biology inventions in Europe.
    Rutz B
    Biotechnol J; 2010 Jan; 5(1):11-3. PubMed ID: 20069577
    [No Abstract]   [Full Text] [Related]  

  • 8. "Obvious to try": a proper patentability standard in the pharmaceutical arts?
    Trask AV
    Fordham Law Rev; 2008 Apr; 76(5):2625-68. PubMed ID: 18546581
    [No Abstract]   [Full Text] [Related]  

  • 9. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

  • 10. US court case to define EST patentability.
    Lawrence S
    Nat Biotechnol; 2005 May; 23(5):513. PubMed ID: 15877055
    [No Abstract]   [Full Text] [Related]  

  • 11. An overview of pharmaceutical cocrystals as intellectual property.
    Trask AV
    Mol Pharm; 2007; 4(3):301-9. PubMed ID: 17477544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animals as inventions: biotechnology and intellectual property rights.
    Sagoff M
    Rep Inst Philos Public Policy; 1996; 16(1):15-9. PubMed ID: 11654360
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intellectual property in natural sciences].
    Twardowski T
    Postepy Biochem; 2008; 54(1):20-3. PubMed ID: 18610578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patenting pluripotence: the next battle for stem cell intellectual property.
    Vrtovec KT; Scott CT
    Nat Biotechnol; 2008 Apr; 26(4):393-5. PubMed ID: 18392018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States.
    Miller CP; Ullrich JW
    Chirality; 2008 Jun; 20(6):762-70. PubMed ID: 18200591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges to obtaining good pharmaceutical patents in Japan: 2009 and beyond.
    Komatani TS
    Pharm Pat Anal; 2013 May; 2(3):325-40. PubMed ID: 24237060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Legal protection of biotechnological inventions. The European Parliament's perspective].
    Palacio Vallelersundi A; Carrasco Pradas DA
    Rev Derecho Genoma Hum; 1998; (8):71-103. PubMed ID: 15839028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European Directive on the Legal Protection of Biotechnological Inventions: scope, status and controversies in a nutshell.
    Hakki MM
    E Law; 2004 Mar; 11(1):E4. PubMed ID: 16903025
    [No Abstract]   [Full Text] [Related]  

  • 19. Realizing two-tiered innovation policy through drug regulation.
    Ridgway WE
    Stanford Law Rev; 2006 Feb; 58(4):1221-50. PubMed ID: 16685807
    [No Abstract]   [Full Text] [Related]  

  • 20. WIPO’s Standing Committee on the Law of Patents meets in Geneva.
    Hemsley A
    Pharm Pat Anal; 2012 Jul; 1(3):239-40. PubMed ID: 24386666
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.